Antifibrogenic therapies in chronic HCV infection.

Current drug targets. Infectious disorders

Volumn 1, Issue 2, 2001, Pages 227-240

  Shimizu, I ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; INTERFERON; OLIGOPEPTIDE; RETINOID; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CYTOTOXIC T LYMPHOCYTE; DRUG ANTAGONISM; HEPATITIS C; HUMAN; IMMUNOLOGY; LIVER CELL; LIVER CIRRHOSIS; PATHOLOGY; REVIEW;

ANTIOXIDANTS; HEPATITIS C, CHRONIC; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; INTERFERONS; LIVER CIRRHOSIS; OLIGOPEPTIDES; RETINOIDS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035428028     PISSN: 15680053     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005014606053     Document Type: Review

References (150)